Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial.
Crimi C, Noto A, Madotto F, Ippolito M, Nolasco S, Campisi R, De Vuono S, Fiorentino G, Pantazopoulos I, Chalkias A, Libra A, Mattei A, Scala R, Clini EM, Ergan B, Lujan M, Winck JC, Giarratano A, Carlucci A, Gregoretti C, Groff P, Cortegiani A; COVID-HIGH Investigators. Crimi C, et al. Thorax. 2023 Apr;78(4):354-361. doi: 10.1136/thoraxjnl-2022-218806. Epub 2022 May 17. Thorax. 2023. PMID: 35580898 Clinical Trial.
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial.
Cortegiani A, Longhini F, Madotto F, Groff P, Scala R, Crimi C, Carlucci A, Bruni A, Garofalo E, Raineri SM, Tonelli R, Comellini V, Lupia E, Vetrugno L, Clini E, Giarratano A, Nava S, Navalesi P, Gregoretti C; H. F.-AECOPD study investigators. Cortegiani A, et al. Crit Care. 2020 Dec 14;24(1):692. doi: 10.1186/s13054-020-03409-0. Crit Care. 2020. PMID: 33317579 Free PMC article. Clinical Trial.
High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial.
Cortegiani A, Longhini F, Carlucci A, Scala R, Groff P, Bruni A, Garofalo E, Taliani MR, Maccari U, Vetrugno L, Lupia E, Misseri G, Comellini V, Giarratano A, Nava S, Navalesi P, Gregoretti C. Cortegiani A, et al. Among authors: taliani mr. Trials. 2019 Jul 22;20(1):450. doi: 10.1186/s13063-019-3514-1. Trials. 2019. PMID: 31331372 Free PMC article.
More on: vitamin K antagonists and cancer.
Agnelli G, Taliani MR, Prandoni P; WODIT Investigators. Agnelli G, et al. Among authors: taliani mr. J Thromb Haemost. 2008 Aug;6(8):1441-2; author reply 1442-3. doi: 10.1111/j.1538-7836.2008.03044.x. Epub 2008 Jun 4. J Thromb Haemost. 2008. PMID: 18532996 Free article. No abstract available.
Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB; Warfarin Optimal Duration Italian Trial (WODIT) Investigators. Santamaria MG, et al. Among authors: taliani mr. Thromb Res. 2005;116(4):301-6. doi: 10.1016/j.thromres.2004.12.012. Epub 2005 Jan 26. Thromb Res. 2005. PMID: 16038714
A prospective study on cardiovascular events after acute pulmonary embolism.
Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, Poggio R, Imberti D, Ageno W, Pogliani E, Porro F, Casazza F. Becattini C, et al. Among authors: taliani mr. Eur Heart J. 2005 Jan;26(1):77-83. doi: 10.1093/eurheartj/ehi018. Epub 2004 Nov 30. Eur Heart J. 2005. PMID: 15615803 Clinical Trial.
18 results